本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Achieve Life Sciences, Inc.

2.58
+0.03001.18%
盤後2.620.0400+1.55%19:44 EDT
成交量:50.07萬
成交額:129.75萬
市值:1.28億
市盈率:-1.93
高:2.62
開:2.60
低:2.56
收:2.55
資料載入中...
2021/12/22

重要事件披露

8-K - Current report
2021/08/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/05/27

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/05/25

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/03/15

重要事件披露

8-K - Current report
2021/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/30

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/30

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses